Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Aging & Mental Health|July 26, 2022
Examining transitions of care among nursing home residents with and without antipsychotic medication useSarah D Holmes, Aida Kuzucan, Nicole Brandt, et al.Emergency Radiology|March 14, 2023
Artificial intelligence CAD tools in trauma imaging: a scoping review from the American Society of Emergency Radiology (ASER) AI/ML Expert PanelDavid Dreizin, Pedro V Staziaki, Garvit D Khatri, et al.The Journal of Urology|April 29, 2014
Obesity and long-term survival after radical prostatectomyHeather J Chalfin, Seung Bae Lee, Byong Chang Jeong, et al.Transfusion|March 8, 2014
Allogeneic versus autologous blood transfusion and survival after radical prostatectomyHeather J Chalfin, Steven M Frank, Zhaoyong Feng, et al.The Journal of Urology|August 21, 2012
Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancerJeffrey J Tosoian, Stacy Loeb, Zhaoyong Feng, et al.The Prostate|September 11, 2013
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experiencePhillip M Pierorazio, Michael A Gorin, Ashley E Ross, et al.Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.Journal of the American Geriatrics Society|June 12, 2024
Sustained IL-6 and sTNF-αR1 levels after hip fracture predict 5-year mortality: A prospective cohort study from the Baltimore Hip StudiesSaionara M A Câmara, Marc C Hochberg, Ram Miller, et al.Nutrients|January 10, 2026
Mitigating Weight Gain Side Effects by Reducing Sugar-Sweetened Beverage Consumption in Youth Newly Prescribed Second-Generation Antipsychotic MedicationKristin Bussell, Heidi Wehring, Susan dosReis, et al.Cancer|December 11, 2014
Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?Zachary Klaassen, Abhay A Singh, Lauren E Howard, et al.Pageof 6